메뉴 건너뛰기




Volumn 11, Issue 4, 2010, Pages 232-238

Lopinavir protein binding in HIV-1-infected pregnant women

Author keywords

Lopinavir; Pharmacokinetics; Plasma proteins; Pregnancy; Protein binding

Indexed keywords

ALBUMIN; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; OROSOMUCOID;

EID: 77950825016     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00767.x     Document Type: Article
Times cited : (44)

References (16)
  • 1
    • 77950789135 scopus 로고    scopus 로고
    • USPHS Task Force Recommendations for the use of antiretroviral drugs in HIV-infected pregnant women for maternal health and interventions to reduce perinatal HIV transmission in the US. Available at, (accessed 29 April 2009)
    • http://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf, USPHS Task Force Recommendations for the use of antiretroviral drugs in HIV-infected pregnant women for maternal health and interventions to reduce perinatal HIV transmission in the US. Available at, (accessed 29 April 2009)
  • 2
    • 13444269471 scopus 로고    scopus 로고
    • Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy
    • Tracy TS, Venkataramanan R, Glover DD. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 2005, 192:633-639.
    • (2005) Am J Obstet Gynecol , vol.192 , pp. 633-639
    • Tracy, T.S.1    Venkataramanan, R.2    Glover, D.D.3    et al4
  • 3
    • 0018848024 scopus 로고
    • Drug disposition and pharmacokinetics in the maternal-placental-fetal unit
    • Krauer B, Krauer F, Hytten FE. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol Ther 1980, 10:301-328.
    • (1980) Pharmacol Ther , vol.10 , pp. 301-328
    • Krauer, B.1    Krauer, F.2    Hytten, F.E.3
  • 4
    • 33748911183 scopus 로고    scopus 로고
    • Reduced lopinavir exposure during pregnancy
    • Stek AM, Mirochnick M, Capparelli E. Reduced lopinavir exposure during pregnancy. AIDS 2006, 20:1931-1939.
    • (2006) AIDS , vol.20 , pp. 1931-1939
    • Stek, A.M.1    Mirochnick, M.2    Capparelli, E.3    et al4
  • 5
    • 62749098712 scopus 로고    scopus 로고
    • Lopinavir exposure with an increased dose during pregnancy
    • Mirochnick M, Best BM, Stek AM. Lopinavir exposure with an increased dose during pregnancy. JAIDS 2008, 49:485-491.
    • (2008) JAIDS , vol.49 , pp. 485-491
    • Mirochnick, M.1    Best, B.M.2    Stek, A.M.3    et al4
  • 6
    • 77950804351 scopus 로고    scopus 로고
    • Total and unbound lopinavir/ritonavir pharmacokinetics in a concentration-guided study of HIV-infected women throughout pregnancy and post-partum. Montreal, Canada, February 2009 [Poster μ946]
    • Kiser J, Mawhinney S, Kinzie K. Total and unbound lopinavir/ritonavir pharmacokinetics in a concentration-guided study of HIV-infected women throughout pregnancy and post-partum. Montreal, Canada, February 2009 [Poster μ946]
    • Kiser, J.1    Mawhinney, S.2    Kinzie, K.3    et al4
  • 7
    • 33748513653 scopus 로고    scopus 로고
    • The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine
    • NIAID AIDS Clinical Trials Group
    • Aweeka FT, Rosenkranz SL, Segal Y. The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. AIDS 2006, 20:1833-1841. NIAID AIDS Clinical Trials Group
    • (2006) AIDS , vol.20 , pp. 1833-1841
    • Aweeka, F.T.1    Rosenkranz, S.L.2    Segal, Y.3    et al4
  • 8
    • 33748143806 scopus 로고    scopus 로고
    • HIV pharmacology: barriers to the eradication of HIV from the CNS
    • McGee B, Smith N, Aweeka F. HIV pharmacology: barriers to the eradication of HIV from the CNS. HIV Clin Trials 2006, 7:142-153.
    • (2006) HIV Clin Trials , vol.7 , pp. 142-153
    • McGee, B.1    Smith, N.2    Aweeka, F.3
  • 9
    • 33644756715 scopus 로고    scopus 로고
    • Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain
    • Summerfield SG, Stevens AJ, Cutler L. Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. J Pharmacol Exp Ther 2006, 316:1282-1290.
    • (2006) J Pharmacol Exp Ther , vol.316 , pp. 1282-1290
    • Summerfield, S.G.1    Stevens, A.J.2    Cutler, L.3    et al4
  • 10
    • 0021359287 scopus 로고
    • Renal function and therapeutic concentrations of phenytoin
    • Liponi DF, Winter ME, Tozer TN. Renal function and therapeutic concentrations of phenytoin. Neurology 1984, 34:395-397.
    • (1984) Neurology , vol.34 , pp. 395-397
    • Liponi, D.F.1    Winter, M.E.2    Tozer, T.N.3
  • 11
    • 0020681892 scopus 로고
    • Serum protein pattern in normal pregnancy with special reference to acute-phase reactants
    • Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. Br J Obstet Gynaecol 1983, 90:139-145.
    • (1983) Br J Obstet Gynaecol , vol.90 , pp. 139-145
    • Haram, K.1    Augensen, K.2    Elsayed, S.3
  • 12
    • 0019394967 scopus 로고
    • Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant
    • Wood M, Wood AJ. Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 1981, 29:522-526.
    • (1981) Clin Pharmacol Ther , vol.29 , pp. 522-526
    • Wood, M.1    Wood, A.J.2
  • 13
    • 0025139714 scopus 로고
    • Plasma protein binding of drugs in pregnancy and in neonates
    • Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokinet 1990, 18:20-36.
    • (1990) Clin Pharmacokinet , vol.18 , pp. 20-36
    • Notarianni, L.J.1
  • 14
    • 0020318252 scopus 로고
    • Plasma protein binding of drugs in pregnancy
    • Perucca E, Crema A. Plasma protein binding of drugs in pregnancy. Clin Pharmacokinet 1982, 7:336-352.
    • (1982) Clin Pharmacokinet , vol.7 , pp. 336-352
    • Perucca, E.1    Crema, A.2
  • 15
    • 33645986955 scopus 로고    scopus 로고
    • Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions
    • Motoya T, Thevanayagam LN, Blaschke TF. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions. HIV Med 2006, 7:122-128.
    • (2006) HIV Med , vol.7 , pp. 122-128
    • Motoya, T.1    Thevanayagam, L.N.2    Blaschke, T.F.3    et al4
  • 16
    • 67650841096 scopus 로고    scopus 로고
    • Binding of lopinavir to human {alpha}1-acid glycoprotein and serum albumin
    • Gulati A, Boudinot D, Gerk PM. Binding of lopinavir to human {alpha}1-acid glycoprotein and serum albumin. Drug Metab Dispos 2009, 37:1572-1575.
    • (2009) Drug Metab Dispos , vol.37 , pp. 1572-1575
    • Gulati, A.1    Boudinot, D.2    Gerk, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.